Cancer Research UK Manchester Institute in Manchester invites a Postdoctoral Scientist to join the Myeloid Cancer Biology group to study how inherited and somatic mutations cooperate to drive AML and MDS.
The role uses Cas12a genome editing in hematopoietic stem cells, creates complex mouse models, and integrates in vivo work with single-cell multiome profiling to uncover therapeutic vulnerabilities.